Sign In to Follow Application
View All Documents & Correspondence

A Process Of Manufacturing Of Non Fibrillating Cellulosic Fibres

Abstract: The present invention provides a process for producing low fibrillating cellulose fibers by a dry-jet-wet spinning process wherein cellulose is treated with a specific ionic liquid based solvent to produce fibers with fibrillating index less than or equal to 3.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 October 2009
Publication Number
14/2012
Publication Type
INA
Invention Field
TEXTILE
Status
Email
Parent Application

Applicants

GRASIM INDUSTRIES LIMITED
BIRLAGRAM, NAGDA 456331, MADHYA PRADESH, INDIA.

Inventors

1. KAPOOR BIR
APT 1603/1604, WING A, PHASE III, LAKE LUCERNE, LAKE HOMES, POWAI MUMBAI 400076
2. LODHA PREETI
C/O PROF MAHESH TIRUMKUDULU, DEPT OF CHEMICAL ENGINEERING, IIT-BOMBAY, POWAI, MUMBAI 400076
3. PATIL PARAG
C/1002, SYNCHRONICITY, OFF. CHANDIVALI FARM ROAD, CHANDIVALI, POWAI, MUMBAI 400072
4. SRIVASTAVA ADITYA
1/4, GRASIM STAFF COLONY, BIRLAGRAM, NAGDA, 456331
5. SHOUCHE KISHORE
48/6, GRASIM STAFF COLONY, BIRLAGRAM, NAGDA, 456331
6. UERDINGEN ERIC
ZEPPELINSTRABE 9, 67346 SPEYER, GERMANY.
7. SIEMER MICHAEL
D3,2, 68159 MANNHEIM
8. WISNIEWSKI THOMAS
OTTO-BECK-STR. 10, 64625 BENSHEIM, GERMANY
9. VAGT UWE
RATHENAUSTRABE 2, 68165 MANNHEIM, GERMANY
10. KLEMENS MASSONNE
HOHENWEG 8, 67098 BAD DURKHEIM, GERMANY.

Specification

FORM-2
THE PATENT ACT, 19'
(39 OF 1970)
&
THE PATENT RULES, 2006
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
A PROCESS OF MANUFACTURING LOW-FIBRILLATING
CELLULOSIC FIBERS
GRASIM INDUSTRIES LIMITED
an Indian Company
Birlagram Nagda 456331, Madhya Pradesh
India
THE FOLLOWING SPECIFICATION PARTICULARLY DESCRIBES THE INVENTION AND THE MANNER IN WHICH IT IS TO BE PERFORMED.

FIELD OF INVENTION
The invention relates to a process for preparing non-fibrillating cellulosic fibers and cellulosic fibers prepared by the process.
DEFINITIONS
The term "Viscose Process" is a process used for the preparation of man-made cellulose fibers made from cellulose which involves the use of solvents such as sodium hydroxide (an alkali), carbon disulfide and acid solution, and wet spinning of the fibers.
The term Lyocell Process is the process for manufacturing of cellulose fibers which involve the use of direct solvents such as N-methyl morpholine oxide (NMMO) to dissolve the cellulose and dry-jet-wet spinning of the fibers.
The term "Wet Spinning Process" in the context of the present invention is a process which involves spinning of the polymer dope directly into a liquid bath.
The term "Dry-Jet-Wet Spinning" in the context of the present invention is a spinning process which involves spinning of the polymer dope through an air gap into a liquid bath.
The term "Ionic Liquids" refer to salts that are stable liquids having extremely low- saturated vapor pressures and good thermal stability.
BACKGROUND OF THE INVENTION
Cellulosic fibers such as cotton, rayon and lyocell are used in the manufacture of textiles and non-wovens.

The conventional method for the commercial preparation of cellulosic fibers is the viscose process. In one of the conventional processes for the manufacture of cellulosic fibers, cellulose prepared from either wood pulp, is treated with sodium hydroxide and then with carbon disulfide to form cellulose xanthate. The cellulose xanthate thus formed is dissolved in dilute solution of sodium hydroxide to obtain a thick solution called viscose. The viscose is then forced through tiny openings in a spinneret into an acid solution, which coagulates it in the form of fine strands of fibers. In the wet spinning method, the process involves spinning of polymer dope directly into a liquid bath. The cellulosic fibers obtained from the viscose process are non-fibrillating, but possess low strength. Further, the viscose process involves the use of hazardous liquids such as carbon disulfide and sulphuric acid thus making entire process not environment friendly.
In another conventional process for manufacturing cellulosic fibers, cellulose is dissolved in a cuprammonium solution to form a solution which is forced through submerged spinnerets into a dilute solution of sulphuric acid, which acts as coagulating agent, to form fibers. The main drawback of the process is that efficient ammonia recovery is difficult to achieve and the process is more expensive than the viscose rayon process.
The cellulose/lyocell fibers are also known to be obtained using a dry jet wet spinning technique using N-methylmorpholine N-oxide hydrate. Although, the dry jet wet spinning process gives significantly higher fiber tenacity and modulus than the conventional wet jet spinning process, the use of NMMO is not desirable due to the fact that NMMO is thermally unstable and is explosive at higher temperature leading to its degradation and generation of coloured compounds that affects the whiteness of the fibers and increasing the cost of the fiber and the fiber prepared from the above process show high fibrillation

tendency, which affects the appearance of the product made from such fibers. Further, to reduce the fibrillation tendency, the conventional fibers are required to be further processed by cross-linking agents or by mechanical, chemical or enzymatic means which further add to the cost of the overall process.
WO 2009/062723 of BASF published on May 22, 2009, relates to a spinning process and discloses use of EMIM octanoate and imidazolium-dialkylphosphates.
WO 2006/000197 and WO 2007/128268 of TITK disclose a spinning process of cellulose in ionic liquid.
WO 2008/133269 of Nisshinbo Industries discloses ionic liquids, wherein the cation (including imidazolium) has at least one alkoxyalkyl group and the anion is dimethyl phosphate and has good solubility of cellulose and fibers are mentioned without any details or examples.
WO2007076979 of BASF discloses a solution system for biopolymers in the form of carbohydrates, solution system containing molten ionic liquid, also additives optionally being contained in the solution system, is described. This solution system contains a protic solvent or a mixture of several protic solvents, and in the case where the protic solvent is solely water, it is present in the solution system in an amount of more than about 5 wt. %. The patent provides a process for regenerated cellulose non-fibrillating spun fibers.
There is, therefore, a need to develop a process, for preparing non-fibrillating cellulosic fibers, which is simple, cost effective, environment friendly and which can overcome the shortcomings of the conventional processes without

requiring the use of harmful solvents. The current invention describes a process of manufacturing low fibrillating cellulosic fibers using dry-jet-wet spinning under specific spinning conditions using ionic liquids as solvents for cellulose.
OBJECTS OF THE INVENTION
It is an object of the invention to provide a process for preparing non-fibrillating cellulosic fibers which is simple, efficient and cost effective.
It is another object of the invention to provide a process for preparing non-fibrillating cellulosic fibers which is environment friendly.
It is another object of the invention to provide a process for preparing non-fibrillating fibers which provides cellulosic fibers with high strength and elongation properties.
It is further object of the invention to provide a process for preparing non-fibrillating -cellulosic fibers which employ the solvents which withstand high temperatures and do not result in the formation of degraded products at higher temperatures.
It is a further object of the invention to provide a process for preparing non-fibrillating cellulosic fibers which employ solvents that can be recycled and reused.
It is still further object of the invention to provide a process for preparing non-fibrillating cellulosic fibers by dry-jet-wet spinning technique.

SUMMARY OF THE INVENTION
Accordingly, the invention provides a process for producing low fibrillating cellulose fibers by a dry-jet-wet spinning process comprising following steps:
a. dissolving cellulose in a solvent system containing at least 50% by weight
of at least one ionic liquid to form a polymer solution of 100 to 1000000
Poise zero shear viscosity wherein the ionic liquid has cations with
heterocyclic ring system containing one or two nitrogen atoms, with each
such nitrogen atom substituted by an alkyl group having 1 to 20 carbon
atoms and anions being at least one selected from the group consisting of a
carboxylate anion of formula Ra-COO" wherein Ra is a alkyl group having 1
to 20 carbon atoms, preferably 7 to 9 carbon atoms, and phosphate anion of
formula Rb-Rc-P04 , Rb and Rc are alkyl groups having 1 to 20 carbon
atoms, preferably having 1 to 5 carbon atoms , and that total number of
carbon atoms in the alkyl groups in the anion and cation being at least 5,
preferably at least 7, most preferably at least 9;
b. spinning fibres from said solution in a spinneret through an air gap of 2 mm
to 50 mm into a coagulation bath comprising 0.01% to 60% of said ionic
liquid, maintained at a temperature between -50 C to 60 C ; and
c. washing and drying the fibers obtained in step (b).
Typically, the concentration of the ionic liquid is at least 70% by weight of the solvent system.
Typically, the ionic liquid is a 1,3-disubstituted imidazolium salt of the formula I


where
Rl and R3 are each, independently of one another, an organic group having 1 to
20 carbon atoms,
R2, R4 and R5 are each, independently of one another, an H atom or an organic group having from 1 to 20 carbon atoms,
X is an anion, being at least one selected from the group consisting of carboxylate anion of formula Ra-COO , wherein Ra is alkyl group having 1 to 20 carbon atoms, preferably Ra is an alkyl group having 6 to 9 carbon atom, and phosphate anion of formula Rb-Rc-P04 , wherein Ra and Rb are alkyl groups having 1 to 20 carbon atoms, preferably having 1 to 5 carbon atoms, and n is 1, 2 or 3.
The total number of carbon atoms in the alkyl groups of the anion and cation being at the most 30, preferably below 26, most preferably below 22.
Typically, X is diethyl phosphate.
The solvent system further comprises at least one solvent selected from the group consisting of water, dimethyl sulfoxide, dimethyl acetamide, dimethyl formamide, N-methyl pyrrolidone and mixtures thereof.

The coagulation bath further comprises at least 40% by weight of a protic solvent selected from the group consisting of water, methanol, ethanol, glycerol, n-propanol, iso-propanol and mixtures thereof.
In preferred embodiment of the present invention ,the ionic liquid is at least one selected from the group consisting of Dibutyl imidazolium acetate, Dipentyl imidazolium acetate, Dihexyl imidazolium acetate, Dibutyl imidazolium octanoate, l-Ethyl-3-methylimidazolium heptanoate, Dipropyl imidazolium octanoate, l-Ethyl-3-rnethyl imidazolium octanoate, l-Ethyl-3-methyl imidazolium nonanoate, l-Ethyl-3-methyl imidazolium decanoate, l-Ethyl-3-methyl imidazolium undecanoate, l-Ethyl-3-methyl imidazolium dodecanoate, l-Ethyl-3-methyl immidazolium diethyl phosphate. Diethyl imidazolium octanoate, and l-Decyl-3-methyl imidazolium acetate.
Typically, the fibres produced in accordance with the present invention have fibrillation index less than or equal to 3.
Detailed Description of the Invention
A process for producing a low fibrillating cellulosic fiber involves treating cellulose with a solvent system, the solvent system contains at least one ionic liquid, such that the cellulose is soluble in the solvent system to form a polymer solution, wherein concentration of cellulose in the polymer solution is in the range of 6% to 20%, spinning the polymer solution through an air gap into a coagulation bath. The coagulation bath contains a solvent containing up to 70 % of ionic liquid. The coagulation bath is maintained at a temperature range of-5°C to 60°C. The fibers emerging from the spinneret are contacted with air or an inert gas. The distance of air gap between the spinneret and coagulation bath is

in the range of 2 mm to 150 mm and absolute humidity in the air is <75 g/cubic meter. The temperature of the air gap is maintained in the range of-5°C to 50°C. The solvent system further comprises at least one solvent selected from the group consisting of water, dimethyl sulfoxide, dimethyl acetamide, dimethyl formamide, N-methyl pyrrolidone and mixtures thereof.
The coagulation bath further comprises at least 30% by weight of a protic solvent selected from the group consisting of water, methanol, ethanol, glycerol, n-propanol, iso-propanol and mixtures thereof.
In preferred embodiment of the present invention, the ionic liquid comprises a cation with a heterocyclic ring system containing at least one nitrogen atom, such as but not limited to imidazolium, pyridinium, pyrazolium, wherein each nitrogen atom is substituted by a C1-C2o alkyl group and the total number of carbon atoms in the alkyl groups in the cation and the anion is at least 5. The total number of carbon atoms in the alkyl groups of the anion and cation being at the most 30, preferably at the most 26, more preferably at the most 22.
The ionic liquid has a general formula I

Rl and R3 are each, independently of one another, an organic molecule having
1 to 20 carbon atoms,
R2, R4 and R5 are each, independently of one another, an H atom or an organic
molecule having from 1 to 20 carbon atoms,
X is an anion

n is 1, 2 or 3
Preferably, the ionic liquid is a 1, 3-disubstituted imidazolium salt wherein the anion in the ionic liquid is at least one selected from the group consisting of a carboxylate anion of formula Ra-COO wherein Ra is a alkyl group containing 1 to 20 carbon atoms, preferably 6 to 12 carbon atoms and dialkyl phosphate anion of formula Rb-Rc-P04 ~ wherein Ra and Rb are alkyl groups containing 1 to 20 carbon atoms, preferably Rb and RC are alkyl groups independently containing 1-5 carbon atoms.
The total number of carbon atoms in the alkyl groups in the cation and the anion is at least 5. The total number of carbon atoms in the alkyl groups of the anion and cation being at the most 30, preferably at the most 22.
In preferred embodiment, the anion is diethyl phosphate.
In preferred embodiment of the present invention the ionic liquid is selected
from a group consisting of Dibutyl imidazolium acetate, Dipentyl imidazolium
acetate, Dihexyl imidazolium acetate, Dibutyl imidazolium octanoate, 1-
Ethyl-3-methyl imidazolium heptanoate, Dipropyl imidazolium octanoate,
1-Ethy 1-3-methyl imidazolium octanoate, l-Ethyl-3-methyl imidazolium nonanoate,l-Ethyl-3-methyl imidazolium decanoate, l-Ethyl-3-methyl imidazolium undecanoate,l-Ethyl-3-methyl imidazolium dodecanoate, l-Ethyl-3-methyl immidazolium diethyl phosphate, Diethyl imidazolium octanoate, and l-Decyl-3-methyl imidazolium acetate.
The cellulosic fibers prepared in accordance with the present invention are low fibrillating fibers.

Examples
Cellulose was dissolved in specific ionic liquid (as given in table 1) to form a 12% polymer solution and spun from a 60 micron hole spinneret through an air gap (as given in the table 1) into a coagulation bath of specific ionic liquid concentration (as given in table 1) maintained at a set temperature (as given in table 1) to form a fiber. The denier and fibrillation property of the fiber was measured. TC in Table 1 is the total number of carbon atoms in the alkyl groups of the anion and cation of the ionic liquid in the solvent system.
Table 1. Spinning Experiments Details including Solvent, Spinning Parameters
and Fiber Properties

SN Specific
Ionic
Liquid TC Zero
Shear
Viscosity,
Poise Air Gap,
mm Solvent %in bath Bath
temp,
degree
Celsius Fiber Denier Fibrillation
1 1-Ethyl 3-
Methyl
Imidazolium
Octanoate 10 10000 2 20 30 1.2 Low
2 1-Ethyl 3-
Methyl
Imidazolium
Octanoate 10 10000 10 20 30 1.2 Low
3 1-Ethyl 3-
Methyl
Imidazolium
Octanoate 10 10000 10 0 50 1.2 Low
4 1-Ethyl 3-
Methyl
Imidazolium
Octanoate 10 10000 10 50 -5 1.2 Low
5 1-Ethyl 3-Methyl 10 10000 10 30 5 1.2 Low

Imidazolium Octanoate
1-Ethyl 3- 10
6 Methyl
Imidazolium
Octanoate 10000 50 0 20 1.2 Low
1-Ethyl 3- 9
8 Methyl
Imidazolium
Heptanoate 10000 10 20 30 1.2 Low
1-Ethyl 3-Methyl 7
8 Imidazolium
Di ethyl
phosphate 15000 10 20 30 1.2 Low
1-Ethyl 3- 11
9 Ethyl
Imidazolium
Octanoate 20000 10 20 30 1.2 Low
1-Propyl- 13
10 Propyl
Imidazolium Octanoate 25000 10 20 30 1.2 Low
1-Decyl 3- 12
11 Methyl
Imidazolium
Acetate 10000 10 20 30 1.2 Low
1-Ethyl 3- 4
12 Methyl
Imidazolium
Acetate 1000 10 0 50 1.2 High
1-Ethyl 3- 4
13 Methyl
Imidazolium
Acetate 1000 10 20 30 1.2 High
1-Ethyl 3- 4
14 Methyl
Imidazolium
Acetate 1000 10 70 -5 1.2 High
Fibrillation:

Take about 0.003 g of 20 mm long cut fibers with 5 ml distilled water in a polypropylene test tube of 1.5 cm inner diameter and 10 cm tube height. Install the tube on a shaker and subject the fiber to 80 Hz and 12 cm amplitude for 90 minutes. Place the treated fiber on a glass slide and observe under the microscope. Fibrillation index is the number of fibrils observed on a 100 micron fiber length using an optical microscope. Fibrillation index of greater than 3 is high fibrillating and equal to or less than 3 is low fibrillating.
TECHNICAL ADVANCEMENT
The process in accordance with the present invention results in the formation of cellulosic spun fibers which are non-fibrillating and are used in various applications such as textiles and non-woven. The ionic liquids used in the process of the invention can be recovered and reused, thus making overall process efficient and economical. The process of present invention does not generate harmful waste products and is, therefore, environment friendly.
While considerable emphasis has been placed herein on the particular features of the preferred embodiment and the improvisation with regards to it, it will be appreciated that various modifications can be made in the preferred embodiments without departing from the principles of the invention. These and the other modifications in the nature of the invention will be apparent to those skilled in the art from disclosure herein, whereby it is to be distinctly understood that the foregoing descriptive matter is to interpreted merely as illustrative of the invention and not as a limitation.

We Claim:
1. A process for producing low fibrillating cellulose fibers by a dry-jet-wet spinning process comprising following steps:
a. dissolving cellulose in a solvent system containing at least 50% of at least
one ionic liquid to form a polymer solution of 100 to 1000000 Poise zero
shear viscosity wherein the ionic liquid has cations with heterocyclic ring
system containing one or two nitrogen atoms, each such nitrogen atom
substituted by an alkyl group having 1 to 20 carbon atoms, and anions
being at least one selected from the group consisting of a carboxylate
anion of formula Ra-COO" wherein Ra is a alkyl group having 1 to 20
carbon atoms, preferably 5 to 9 carbon atoms, and phosphate anion of
formula Rb-Rc-P04, Rb and Rc are alkyl groups having 1 to 20 carbon
atoms, preferably having 1 to 5 carbon atoms, and total number of carbon
atoms in the alkyl groups in the anion and cation being at least 5,
preferably 7, most preferably at least 9 ;
b. spinning fibres from said solution in a spinneret through an air gap of 2
mm to 50 mm into a coagulation bath comprising 0.01% to 70% by
weight of said ionic liquid, maintained at a temperature between -5 °C to
60°C;and
c. washing and drying the fibers obtained in step (b).

2. The process as claimed in claim 1, where in the total number of carbon atoms in the alkyl groups of the anion and cation being at the most 30, preferably below 26, most preferably below 22.
3. The process as claimed in claim 1, wherein the ionic liquid is a 1,3-disubstituted imidazolium salt of the formula I

where,
Rl and R3 are each, independently of one another, an organic group having
1 to 20 carbon atoms, preferably 1 to 4 carbon atoms;
R2, R4 and R5 are each, independently of one another, an H atom or an organic group having from 1 to 20 carbon atoms, preferably R2, R4 and R5 are each H atom;
X is an anion, anion being at least one selected from the group consisting of a carboxylate anion of formula Ra-COO" wherein Ra is a alkyl group having 1 to 20 carbon atoms, preferably 5 to 9 carbon atoms, and phosphate anion of formula Rb-Rc-PO4, Rb and Re are alkyl groups having 1 to 20 carbon atoms, preferably having 1 to 5 carbon atoms; and
n is 1, 2 or 3.

4. The process as claimed in claim 3, wherein Rl and R3 are same.
5. The process as claimed in claim 3, wherein X is diethyl phosphate.
6. The process as claimed in claim 1 wherein the concentration of the ionic liquid is at least 70% by weight of the solvent system.
7. The process as claimed in claim 1 wherein the solvent system further comprises at least one solvent selected from the group consisting of water, dimethyl sulfoxide, dimethyl acetamide, dimethyl formamide, N-methyl pyrrolidone and mixtures thereof.
8. The process as claimed in claim 1, wherein the coagulation bath further
comprises at least 40% by weight of a protic solvent selected from the group
consisting of water, methanol, ethanol, glycerol, n-propanol, iso-propanol
and mixtures thereof.
9. The process as claimed in any one of the preceding claims, wherein the ionic
liquid is at least one selected from the group consisting of;
Dibutyl imidazolium acetate, Dipentyl imidazolium acetate, Dihexyl imidazolium acetate, Dibutyl imidazolium octanoate, l-Ethyl-3-methyl imidazolium heptanoate,

Dipropyl imidazolium octanoate, l-EthyI-3-methyl imidazolium-octanoate, 1 -Ethyl-3-methyl imidazolium-nonanoate, 1 -Ethyl-3-methyI imidazolium-decanoate, 1 -Ethy 1-3-methyl imidazolium-undecanoate, 1 -EthyI-3-methyl imidazolium-dodecanoate, l-Ethyl-3-methyl immidazolium diethyl phosphate, Diethyl imidazolium octanoate and l-Decyl-3-methyl imidazolium acetate.
10. The fibres produced in accordance with the claim 1 having fibrillation index less than or equal to 3.

Documents

Application Documents

# Name Date
1 2333-MUM-2009- AFR.pdf 2022-10-10
1 2333-MUM-2009-FORM 1(11-11-2009).pdf 2009-11-11
2 2333-MUM-2009-AbandonedLetter.pdf 2019-01-03
2 2333-MUM-2009-CORRESPONDENCE(11-11-2009).pdf 2009-11-11
3 2333-MUM-2009-FORM 3 [07-12-2018(online)].pdf 2018-12-07
3 2333-MUM-2009-FORM 3 [06-10-2017(online)].pdf 2017-10-06
4 2333-MUM-2009-FORM 5(5-10-2010).pdf 2018-08-10
4 2333-MUM-2009-ABSTRACT(5-10-2010).pdf 2018-08-10
5 2333-mum-2009-form 3.pdf 2018-08-10
5 2333-MUM-2009-ANNEXURE TO FORM 3(2-7-2015).pdf 2018-08-10
6 2333-MUM-2009-Form 3-140715.pdf 2018-08-10
6 2333-MUM-2009-CLAIMS(5-10-2010).pdf 2018-08-10
7 2333-MUM-2009-FORM 3(23-9-2013).pdf 2018-08-10
7 2333-MUM-2009-CORRESPONDENCE(11-4-2012).pdf 2018-08-10
8 2333-mum-2009-form 26.pdf 2018-08-10
8 2333-MUM-2009-CORRESPONDENCE(2-7-2015).pdf 2018-08-10
9 2333-MUM-2009-CORRESPONDENCE(23-9-2013).pdf 2018-08-10
9 2333-mum-2009-form 2.pdf 2018-08-10
10 2333-MUM-2009-CORRESPONDENCE(30-5-2013).pdf 2018-08-10
11 2333-MUM-2009-CORRESPONDENCE(5-10-2010).pdf 2018-08-10
11 2333-mum-2009-form 2(title page).pdf 2018-08-10
12 2333-MUM-2009-Correspondence-140715.pdf 2018-08-10
12 2333-MUM-2009-FORM 2(TITLE PAGE)-(5-10-2010).pdf 2018-08-10
13 2333-mum-2009-correspondence.pdf 2018-08-10
13 2333-mum-2009-form 2(5-10-2010).pdf 2018-08-10
14 2333-MUM-2009-DESCRIPTION(COMPLETE)-(5-10-2010).pdf 2018-08-10
14 2333-MUM-2009-FORM 18(30-5-2013).pdf 2018-08-10
15 2333-mum-2009-form 1.pdf 2018-08-10
16 2333-mum-2009-description(provisional).pdf 2018-08-10
16 2333-MUM-2009-FER.pdf 2018-08-10
17 2333-mum-2009-description(provisional).pdf 2018-08-10
17 2333-MUM-2009-FER.pdf 2018-08-10
18 2333-mum-2009-form 1.pdf 2018-08-10
19 2333-MUM-2009-FORM 18(30-5-2013).pdf 2018-08-10
19 2333-MUM-2009-DESCRIPTION(COMPLETE)-(5-10-2010).pdf 2018-08-10
20 2333-mum-2009-correspondence.pdf 2018-08-10
20 2333-mum-2009-form 2(5-10-2010).pdf 2018-08-10
21 2333-MUM-2009-Correspondence-140715.pdf 2018-08-10
21 2333-MUM-2009-FORM 2(TITLE PAGE)-(5-10-2010).pdf 2018-08-10
22 2333-MUM-2009-CORRESPONDENCE(5-10-2010).pdf 2018-08-10
22 2333-mum-2009-form 2(title page).pdf 2018-08-10
23 2333-MUM-2009-CORRESPONDENCE(30-5-2013).pdf 2018-08-10
24 2333-MUM-2009-CORRESPONDENCE(23-9-2013).pdf 2018-08-10
24 2333-mum-2009-form 2.pdf 2018-08-10
25 2333-mum-2009-form 26.pdf 2018-08-10
25 2333-MUM-2009-CORRESPONDENCE(2-7-2015).pdf 2018-08-10
26 2333-MUM-2009-CORRESPONDENCE(11-4-2012).pdf 2018-08-10
26 2333-MUM-2009-FORM 3(23-9-2013).pdf 2018-08-10
27 2333-MUM-2009-Form 3-140715.pdf 2018-08-10
27 2333-MUM-2009-CLAIMS(5-10-2010).pdf 2018-08-10
28 2333-mum-2009-form 3.pdf 2018-08-10
28 2333-MUM-2009-ANNEXURE TO FORM 3(2-7-2015).pdf 2018-08-10
29 2333-MUM-2009-FORM 5(5-10-2010).pdf 2018-08-10
29 2333-MUM-2009-ABSTRACT(5-10-2010).pdf 2018-08-10
30 2333-MUM-2009-FORM 3 [07-12-2018(online)].pdf 2018-12-07
30 2333-MUM-2009-FORM 3 [06-10-2017(online)].pdf 2017-10-06
31 2333-MUM-2009-CORRESPONDENCE(11-11-2009).pdf 2009-11-11
31 2333-MUM-2009-AbandonedLetter.pdf 2019-01-03
32 2333-MUM-2009- AFR.pdf 2022-10-10
32 2333-MUM-2009-FORM 1(11-11-2009).pdf 2009-11-11

Search Strategy

1 2333-MUM-2009APROCESSOFMANUFACTURINGOFNONFIBRILLATINGCELLULOSICFIBRES_22-09-2017.pdf